Optimizing circadian drug infusion schedules towards personalized cancer chronotherapy
Fig 7
Patient data best-fit of oxaliplatin PK model.
Each subplot is an individual patient data, fit to the model independently. (A) shows plasma ultrafiltrate platinum concentrations, and (B) shows plasma total platinum concentrations. PK data for Patient 11 was missing.